CD8A and infection: We found that the SKO and DKO mice developed stronger PICV-specific CD8+ T cells than WT mice, with the greatest levels of differences at day 14 post infection when tetramer+ CD8+ T cells peaked for both of the KO mouse lines (Figure 4B).